Bioresorbable Vascular Scaffold Korean Expert Panel Report
- Authors
- Ahn, Jung-Min; Park, Duk-Woo; Hong, Sung Jin; Ahn, Young Keun; Hahn, Joo-Yong; Kim, Won-Jang; Hong, Soon Jun; Nam, Chang-Wook; Kang, Do-Yoon; Lee, Seung-Yul; Chun, Woo Jung; Heo, Jung Ho; Cho, Deok-Kyu; Kim, Jin Won; Her, Sung-Ho; Kim, Sang Wook; Yoo, Sang-Yong; Hong, Myeong-Ki; Tahk, Seung-Jea; Kim, Kee-Sik; Kim, Moo Hyun; Jang, Yangsoo; Park, Seung-Jung
- Issue Date
- 11월-2017
- Publisher
- KOREAN SOC CARDIOLOGY
- Keywords
- Coronary disease; Bioresorbable vascular scaffold; Stents; Thrombosis
- Citation
- KOREAN CIRCULATION JOURNAL, v.47, no.6, pp.795 - 810
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- KOREAN CIRCULATION JOURNAL
- Volume
- 47
- Number
- 6
- Start Page
- 795
- End Page
- 810
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/81772
- DOI
- 10.4070/kcj.2017.0300
- ISSN
- 1738-5520
- Abstract
- Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural support and drug release to prevent early recoil or restenosis, and then degrades into nontoxic compounds to avoid late complications related with metallic drug-eluting stents (DESs). BRS has several putative advantages. However, recent randomized trials and registry studies raised clinical concerns about the safety and efficacy of first generation BRS. In addition, the general guidance for the optimal practice with BRS has not been suggested due to limited long-term clinical data in Korea. To address the safety and efficacy of BRS, we reviewed the clinical evidence of BRS implantation, and suggested the appropriate criteria for patient and lesion selection, scaffold implantation technique, and management.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.